Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids.

NCT00809822 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Bullous Pemphigoid

Interventions

DRUG: NPB-01
DRUG: Placebo

Sponsor

Nihon Pharmaceutical Co., Ltd